CapsoVision, Inc (CV) stock
CVNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30383% above fair value
$6.03−0.24 (-3.83%)
Close on Nov 13, 2026Market cap $301.78MP/E –Yield –
CapsoVision gross margin
Gross margin is gross profit as a percentage of revenue.
CapsoVision's gross margin for the twelve months ending Sep 30, 2026 was 49.7%. For fiscal 2025 it was 52.9%, against 54.2% the year before.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 52.9% | −1.3 |
| FY2024 | Dec 31, 2024 | 54.2% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 49.4% | −4.7 |
| Q2 FY2026 | Jun 30, 2026 | 51.4% | −3.3 |
| Q1 FY2026 | Mar 31, 2026 | 47.6% | −6.1 |
| Q4 FY2025 | Dec 31, 2025 | 49.9% | −0.4 |
| Q3 FY2025 | Sep 30, 2025 | 54.1% | −1.8 |
| Q2 FY2025 | Jun 30, 2025 | 54.6% | −1.4 |
| Q1 FY2025 | Mar 31, 2025 | 53.7% | – |
| Q4 FY2024 | Dec 31, 2024 | 50.2% | – |
| Q3 FY2024 | Sep 30, 2024 | 55.9% | – |
| Q2 FY2024 | Jun 30, 2024 | 56.0% | – |
See a number that looks wrong?